← Back
$TPST All transactions

Tempest Therapeutics, Inc.

▲ BUY
9 / 10

Conviction

$ Value

$500K

Shares

231,482

Price

$2

Filed

Mar 25

Why this score? (9/10)
  • Open market buy (+3)
  • Trade value >= $250K (+1)
  • C-suite insider (+2)
  • Director (+1)
  • 10%+ owner (+1)
  • Not a 10b5-1 plan (+1)

Insider

Name

Angel Matthew

Title

CEO and President

CIK

0001931356

Roles

Director Officer 10% Owner

Transaction Details

Transaction Date

2026-03-24

Code

P

Table

Non-Derivative

Ownership

Indirect

Equity Swap

No

Shares After

231,482

Footnotes

The shares are held by Factor Bioscience Inc. ("Factor"). The Reporting Peron is the chief executive officer and chairman of the board of directors of Factor and disclaims beneficial ownership of these securities, except to the extent of his proportionate pecuniary interest therein. | The shares reported herein give effect to the pro rata distributions of shares by Erigen LLC for no additional consideration to its members, subsequent to the Reporting Person's last Section 16 filing reporting ownership of the Issuer's Common Stock. As the distribution of such shares constituted only a change in the form the Reporting Person's ownership in such shares, the Reporting Person was not required to report the distribution pursuant to Section 16.

Filing Info

Accession No.

0001931356-26-000011

Form Type

4

Issuer CIK

0001544227

Angel Matthew's History

Date Ticker Type Value
2026-03-24 TPST $500K
2026-02-04 TPST A $0

Other Insiders at TPST (90d)

Insider Bought Sold Last
Pellizzari Christine A 2026-01-27
NICHOL GEOFFREY 2026-01-27
RAAB MICHAEL 2026-01-27
Maestas Nicholas
Chief Financial Officer
2026-03-31
Simantov Ronit 2026-01-27
Angel Matthew
CEO and President
2026-02-04
Trojanowski Justin
Corporate Controller
2026-03-31